Tower Research Capital (TRC)’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25
| Closed | – | – | 6620 |
|
|
2023
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 6666 |
|
|
2022
Q4 | $0 | Sell |
25
-16,523
| -100% | – | ﹤0.01% | 6718 |
|
|
2022
Q3 | $7K | Buy |
16,548
+1,546
| +10% | +$654 | ﹤0.01% | 4970 |
|
|
2022
Q2 | $13K | Buy |
15,002
+14,255
| +1,908% | +$12.4K | ﹤0.01% | 4256 |
|
|
2022
Q1 | $4K | Sell |
747
-8,670
| -92% | -$46.4K | ﹤0.01% | 5311 |
|
|
2021
Q4 | $92K | Sell |
9,417
-88
| -0.9% | -$860 | ﹤0.01% | 2285 |
|
|
2021
Q3 | $170K | Buy |
9,505
+5,948
| +167% | +$106K | ﹤0.01% | 1964 |
|
|
2021
Q2 | $87K | Buy |
3,557
+255
| +8% | +$6.24K | ﹤0.01% | 2541 |
|
|
2021
Q1 | $87K | Sell |
3,302
-541
| -14% | -$14.3K | ﹤0.01% | 2697 |
|
|
2020
Q4 | $29K | Sell |
3,843
-30,497
| -89% | -$230K | ﹤0.01% | 3610 |
|
|
2020
Q3 | $172K | Buy |
34,340
+24,677
| +255% | +$124K | ﹤0.01% | 2708 |
|
|
2020
Q2 | $58K | Buy |
9,663
+9,075
| +1,543% | +$54.5K | ﹤0.01% | 2943 |
|
|
2020
Q1 | $3K | Sell |
588
-6,134
| -91% | -$31.3K | ﹤0.01% | 2515 |
|
|
2019
Q4 | $64K | Buy |
6,722
+5,826
| +650% | +$55.5K | 0.01% | 1190 |
|
|
2019
Q3 | $7K | Sell |
896
-3,382
| -79% | -$26.4K | ﹤0.01% | 3172 |
|
|
2019
Q2 | $67K | Buy |
+4,278
| New | +$67K | ﹤0.01% | 1417 |
|
|
2019
Q1 | – | Sell |
-1,377
| Closed | -$22K | – | 4475 |
|
|
2018
Q4 | $22K | Buy |
+1,377
| New | +$22K | ﹤0.01% | 1887 |
|